News

Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...
Discover 7 powerful signs your liver is healing after you stop drinking alcohol, from improved energy to better digestion and ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
From 2006 to 2019, age-adjusted mortality for liver disease in the US increased by 14% overall and by 24% during COVID, from 2019 through 2021.
Early menopause before age 50 significantly increases the risk of fatty liver disease and metabolic disorders, according to ...
Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...
Specific populations at risk of liver decline are those with obesity, diabetes, and polycystic ovarian syndrome, says Gareth ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...
Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...